Zygel (cannabidiol gel) / Zynerba, Paragon Biosci  >>  Phase 1
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zygel (cannabidiol gel) / Paragon Biosci
ACTRN12615001025527: Study of ZYN002 (transdermal gel) in Healthy Volunteers and Patients with Epilepsy

Terminated
1
44
 
Zynerba Pharmaceuticals Inc., Zynerba Pharmaceuticals Inc.
Epilepsy
 
 
ACTRN12616000104459: A multiple dose study of ZYN002 (transdermal gel) in Healthy Volunteers and Patients with Epilepsy

Completed
1
36
 
Zynerba Pharmaceuticals Inc., Zynerba Pharmaceuticals Inc.
Epilepsy
 
 
ACTRN12616000674437: Study of ZYN002 (transdermal gel) in 42 Healthy Volunteers

Completed
1
42
 
Zynerba Pharmaceuticals Inc., Zynerba Pharmaceuticals Inc.
Epilepsy
 
 
ACTRN12618000183280: Study of ZYN002 (cannabidiol gel) in 40 Healthy Volunteers

Completed
1
40
 
Zynerba Pharmaceuticals Pty. Ltd., Zynerba Pharmaceuticals Pty. Ltd.
Fragile X Syndrome, Epilepsy, Osteoarthritis
 
 

Download Options